Home

Samsara BioCapital reported a 61.2% stake in Kalaris Therapeutics KLRS · 11,448,081 sh

Trade details

Type
5% stake report
Report
13D
Stake
61.2%
Last report
First report
Shares held
11,448,081 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/03/18
Filed
25/03/25

First 5%+ report · 61.2% stake

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Samsara BioCapital's other 5% stake reports

  • Samsara BioCapital

    5% stakePMV Pharmaceuticals

    9.9% stake

    Filed 09/15

  • Samsara BioCapital

    5% stakeEloxx Pharmaceuticals

    9.9% stake

    Filed 08/14

  • Samsara BioCapital

    5% stakeRani Therapeutics Holdings

    9.9% stake

    Filed 05/28

  • Samsara BioCapital

    5% stakeKalaris Therapeutics

    54.2% stake

    Filed 05/22

  • Samsara BioCapital

    5% stakeSutro Biopharma

    6.4% stake

    Filed 05/15

Samsara BioCapital reported a 61.2% stake in Kalaris Therapeutics KLRS · 11,448,081 sh | Whalegun